Merck buys Sirna Therapeutics $1.1 billion-Tiny biotech company developing drugs based on Nobel technology
Roche Holding and Alnylam Pharmaceuticals Form $1 Billion Alliance on RNAi Therapeutics
Short interfering RNA (siRNA): tool or
therapeutic?
Better Than Stem Cells? Short Interfering RNA Hold Promise For Dramatic New Treatments
Pharmaprojects Update Analysis
ToleroTech in London life science 2002
